Survival in severe aplastic anemia (SAA) has markedly improved in the past 4 decades
because of advances in hematopoietic stem cell transplantation, immunosuppressive …

Evidence has accumulated in the recent years further corroborating an immune-mediated
process underlying aplastic anemia pathogenesis. Hematopoietic stem-cell transplantation …

Inherited defects in adenosine deaminase (ADA) cause a subtype of severe combined
immunodeficiency (SCID) known as severe combined immune deficiency caused by …

Although allogeneic hematopoietic stem cell transplantation (HSCT) remains the only
curative treatment for patients with Fanconi anemia (FA), published series mostly refer to …

The progress in aplastic anaemia (AA) management is one of success. Once an obscure
entity resulting in death in most affected can now be successfully treated with either …

An immune basis for most patients with aplastic anemia (AA) provides a rationale for
immunosuppressive therapy (IST), using antithmyocyte globulin and cyclosporine as one …

The human leukocyte antigen (HLA) class I and class II loci are the most polymorphic genes
in the human genome. Hematopoietic stem cell transplantation requires allele‐level HLA …

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body
irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective …

Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Hematopoietic stem cell transplantation is the accepted therapy of choice for a variety of
malignant and non-malignant diseases in children and adults. Initially developed as rescue …